XML 54 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Business Segment Information
12 Months Ended
Oct. 31, 2019
Segment Reporting [Abstract]  
Business Segment Information Business Segment Information
Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.

Total net sales include sales to customers as reported in our Consolidated Statements of Income and sales between geographic areas that are priced at terms that allow for a reasonable profit for the seller. Operating income (loss) is total net sales less cost of sales, selling, general and administrative expenses, research and development expenses, amortization and intangible impairments. Corporate operating loss is principally corporate headquarters expense. Interest expense, and other income and expenses are not allocated to individual segments.
No customers accounted for 10% or more of our consolidated net revenue in the fiscal 2019 and 2018. One customer, a CooperVision contact lens distributor, accounted for approximately 10% of our consolidated net revenue in the fiscal 2017.
Identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets. Long-lived assets are net property, plant and equipment.
The following table presents a summary of our business segment net sales:
(In millions)
2019
 
2018
 
2017
CooperVision net sales by category:

 

 

Toric lens
$
620.0

 
$
591.4

 
$
526.8

Multifocal lens
202.9

 
196.6

 
177.2

Single-use sphere lens
568.2

 
520.1

 
438.3

Non single-use sphere and other
581.8

 
573.9

 
531.8

Total CooperVision net sales
1,972.9

 
1,882.0

 
1,674.1

CooperSurgical net sales by category:
 
 
 
 
 
Office and surgical products
422.4

 
400.4

 
214.7

             Fertility
258.1

 
250.4

 
250.2

Total CooperSurgical net sales
680.5

 
650.8

 
464.9

Total net sales
$
2,653.4

 
$
2,532.8

 
$
2,139.0


Information by business segment for each of the years in the three-year period ended October 31, 2019, follows:
(In millions)
CooperVision
 
CooperSurgical
 
Corporate
 
Consolidated
2019

 

 

 

Net sales
$
1,972.9

 
$
680.5

 
$


$
2,653.4

Operating income (loss)
$
506.4

 
$
87.9

 
$
(47.6
)

$
546.7

Interest expense
 
 
 
 
 
 
68.0

Other expense, net
 
 
 
 
 
 
1.3

Income before income taxes
 
 
 
 
 
 
$
477.4

Identifiable assets
$
3,911.6

 
$
2,189.8

 
$
173.1


$
6,274.5

Depreciation expense
$
125.8

 
$
9.0

 
$
0.2


$
135.0

Amortization expense
$
40.9

 
$
104.9

 
$


$
145.8

Capital expenditures
$
259.0

 
$
33.1

 
$


$
292.1

2018

 

 

 

Net sales
$
1,882.0


$
650.8


$

 
$
2,532.8

Operating income (loss)
$
479.8


$
(19.9
)

$
(56.8
)
 
$
403.1

Interest expense
 
 
 
 
 
 
82.7

Other (income), net
 
 
 
 
 
 
(11.5
)
Income before income taxes
 
 
 
 
 
 
$
331.9

Identifiable assets
$
3,746.0


$
2,201.7


$
165.1

 
$
6,112.8

Depreciation expense
$
120.1


$
8.1


$
0.2

 
$
128.4

Amortization expense
$
43.6


$
103.1


$

 
$
146.7

Capital expenditures
$
178.4


$
15.1


$
0.1

 
$
193.6

2017

 

 

 


Net sales
$
1,674.1

  
$
464.9

  
$

 
$
2,139.0

Operating income (loss)
$
418.4

  
$
58.5

  
$
(47.8
)
 
$
429.1

Interest expense
 
 
 
 
 
 
33.4

Other expense, net
 
 
 
 
 
 
1.7

Income before income taxes
 
 
 
 
 
 
$
394.0

Identifiable assets
$
3,562.6

  
$
1,107.5

  
$
188.6

 
$
4,858.7

Depreciation expense
$
115.0

  
$
4.7

  
$
0.3

 
$
120.0

Amortization expense
$
36.7

  
$
31.7

  
$

 
$
68.4

Capital expenditures
$
108.2

  
$
18.9

  
$
0.1

 
$
127.2



Information by geographical area by country of domicile for each of the years in the three-year period ended October 31, 2019, follows:
 
(In millions)
United
States
  
Europe
 
Rest of
World, Other
Eliminations
& Corporate
 
Consolidated
2019
 
  
 
 
 
 
 
Net sales to unaffiliated customers
$
1,211.8


$
854.8


$
586.8


$
2,653.4

Sales between geographic areas
650.7


300.8


(951.5
)


Net sales
$
1,862.5


$
1,155.6


$
(364.7
)

$
2,653.4

Operating income
$
83.2


$
29.3


$
434.2


$
546.7

Property, plant and equipment, net
$
626.5


$
358.8


$
146.8


$
1,132.1

2018
 
  
 
 
 
 
 
Sales to unaffiliated customers
$
1,162.2

  
$
846.5

 
$
524.1

 
$
2,532.8

Sales between geographic areas
274.3

  
407.1

 
(681.4
)
 

Net sales
$
1,436.5

  
$
1,253.6

 
$
(157.3
)
 
$
2,532.8

Operating (loss) income
$
(39.3
)
  
$
(16.8
)
 
$
459.2

 
$
403.1

Property, plant and equipment, net
$
516.7

  
$
340.7

 
$
118.6

 
$
976.0

2017
 
  
 
 
 
 
 
Sales to unaffiliated customers
$
931.1

  
$
746.2

 
$
461.7

 
$
2,139.0

Sales between geographic areas
255.7

  
440.5

 
(696.2
)
 

Net sales
$
1,186.8

  
$
1,186.7

 
$
(234.5
)
 
$
2,139.0

Operating income
$
37.8

  
$
1.6

 
$
389.7

 
$
429.1

Property, plant and equipment, net
$
472.8

  
$
352.3

 
$
85.0

 
$
910.1